In what can be considered a “historic” move forward in the fight against malaria, the World Health Organization (WHO) has recommended...

Despite significant progress achieved in the past years, malaria remains a major cause of morbidity and mortality, especially in children...

The Innovative Medicines Initiative 2 (IMI2) Joint Undertaking mobilised more than € 33 million to support Inno4vac, an innovative...

EVI and CEPI signed a Memorandum of Understanding that establishes a vaccinology training collaboration with the TRANSVAC2 project.

Zika virus infection is a vector borne disease which has called the attention of the international community due to a large outbreak in...

‘Vaccines bring us closer’ across the world, organisations and generations This year, under the theme ‘Vaccines bring us closer’, both...

World Immunization Week: 24 – 30 April 2021 Vaccines protect people of all ages against disease.

The World Malaria Day on April 25th marks the progress in fighting malaria, highlighting the responsibility we all have to end this...

...to develop the next generation of safe, affordable and effective TB vaccines TBVI and EVI are building on a strong TB vaccine R&D...

A new review article on Placental Malaria has been published in Frontiers in Immunology. The publication, entitled Progress and Insights...

EVI to lead Immune Monitoring in pan-European vaccine trial network, VACCELERATE, as part of €150 million EU investment in research to...

February 11th marks the International Day of Women and Girls in Science. It is an opportunity to promote full and equal access and...

Knowledge sharing and capacity building are key to advance scientific research and innovation. One of the main objectives of the...

The VAC2VAC project was presented on February 3rd, 2021 at the scientific conference “Towards replacement of animals for scientific...

Every year on January 30th, the global health and development community comes together to acknowledge World Neglected Tropical Disease...

Novel approach for minimizing investment risks and stretching limited budgets has 375 infectious disease innovations under development...

The European Vaccine Initiative (EVI) has selected McKinsey & Company to develop a business plan, including suitable governance structure...

We recently worked with Health Awareness on the 2020 Value of Vaccines campaign. A printed publication was enclosed within every copy of...

Recently the World Malaria report reviewed 20 years of malaria response. Since 2000, 7.6 million lives have been saved globally and 1.5...

We are launching our Advent Calendar for the month of December. Get to know something about who we are and what we do, each day. Follow...

The global HIV/AIDS burden has decreased significantly in the last 10 years. New HIV infections have been reduced by 23% since 2010...

The RICH Symposium on “Research Infrastructures as Engines for Maximising Impact of Horizon Europe” brought together around 180...

On his latest interview, European Vaccine Initiative's executive director, Ole Olesen, shares his experience during the first nine months...

Developing a vaccine is a time-consuming and complex process, requiring a combination of specialized skills and technical capacities not...